NERV Q3 2022 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena

NERVMinerva Neurosciences, Inc.

$53M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$5M

Net Income

-$7M

EPS (Diluted)

$-1.61

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$60M

Total Liabilities

$74M

Stockholders' Equity

-$14M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$5M	-$8M	+30.7%
Net Income	-$7M	-$9M	+25.0%